Literature DB >> 6826252

Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes.

J R Ortaldo, A Mantovani, D Hobbs, M Rubinstein, S Pestka, R B Herberman.   

Abstract

Ten species of purified human leukocyte interferon were tested for their ability to modulate the cytolytic activity of natural killer (NK) cells and the cytolytic and cytostatic activities of monocytes. The interferon species were tested at several antiviral titers and examined for quantitative differences in their ability to modulate immunological function. At the higher doses of interferon (i.e., greater than 500 units) all of the interferon species demonstrated significant augmentation of cytolysis and cytostasis. However, when low levels (i.e., 10-50 units) of interferon were employed, appreciable differences between the various interferon species were seen. A similar pattern of relative potency among the various species of pure leukocyte interferon was seen for augmentation of cytolysis by monocytes and NK cells. In contrast, a different pattern of relative potency was observed for augmentation of cytostasis. These results demonstrated substantial quantitative differences (as much as 100-fold) in the ability of the various species of human leukocyte interferon to induce significant levels of augmentation of these cell-mediated functions. Such results should have significant impact in choosing a specific interferon species for appropriate clinical trials.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6826252     DOI: 10.1002/ijc.2910310306

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  Interferon-zeta/limitin: novel type I interferon that displays a narrow range of biological activity.

Authors:  Kenji Oritani; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

2.  Plasmacytoid dendritic cells reduce HIV production in elite controllers.

Authors:  K Machmach; M Leal; C Gras; P Viciana; M Genebat; E Franco; F Boufassa; O Lambotte; J P Herbeuval; E Ruiz-Mateos
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

3.  Failure of intraventricular gammaglobulin and alpha interferon for persistent encephalitis in congenital hypogammaglobulinaemia.

Authors:  D M Roberton; I Jack; W Joshi; F Law; C S Hosking
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

4.  A species of human alpha interferon that lacks the ability to boost human natural killer activity.

Authors:  J R Ortaldo; R B Herberman; C Harvey; P Osheroff; Y C Pan; B Kelder; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

5.  Effects of in vivo hyperthermia on natural killer cell activity, in vitro proliferative responses and blood mononuclear cell subpopulations.

Authors:  M Kappel; C Stadeager; N Tvede; H Galbo; B K Pedersen
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

6.  The inhibitory effect of human interferon alpha on the generation of lymphokine-activated killer activity.

Authors:  Y Tokuda; N Ebina; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum.

Authors:  A A Gaspari; T A Fleisher; K H Kraemer
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis.

Authors:  Yoshio Katamura; Hiroshi Aikata; Shintaro Takaki; Takahiro Azakami; Tomokazu Kawaoka; Koji Waki; Akira Hiramatsu; Yoshiiku Kawakami; Shoichi Takahashi; Masahiro Kenjo; Naoyuki Toyota; Katsuhide Ito; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2009-03-28       Impact factor: 7.527

9.  Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisolone.

Authors:  E Braakman; P Treep-van Leeuwen; R J ten Berge; P T Schellekens; C J Lucas
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

10.  Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.

Authors:  E Braakman; A van Tunen; A Meager; C J Lucas
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.